Physician profile
Yan Dong
NPI 1043507577
$32,181.59
in general payments reported to CMS, 2019-2025
11 companies · $9,887 in 2025
The $9,887 reported for 2025 was more than what 80% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $657 · 2021: $5,236 · 2022: $2,549 · 2023: $1,632 · 2024: $1,576 · 2025: $9,887.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,017 · Food and Beverage: $6,078.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,016.74 |
| Food and Beverage | $6,078.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $8,072.90 | 2019-2025 | Farapulse, Watchman Flx, General - Ep |
| Abbott Laboratories | $6,442.15 | 2019-2025 | Ensite, Ensite Precision, Confirm Rx |
| Medtronic Vascular, INC. | $5,628.81 | 2019-2020 | |
| Biotronik INC. | $4,973.40 | 2023-2025 | Acticor 7 Vr-T Dx, Amvia Edge |
| Medtronic, INC. | $4,772.98 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Pulseselect |
| Biosense Webster, INC. | $988.71 | 2020-2025 | Carto 3 |
| Medical Device Business Services, INC. | $673.37 | 2021 | |
| Impulse Dynamics (USA) INC. | $302.85 | 2024-2025 | Optimizer |
| Cardiofocus, INC. | $177.65 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $131.27 | 2020-2021 | |
| Convatec INC. | $17.50 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yan Dong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.